Bridgefront Capital’s DexCom DXCM Stock Holding History

Bridgefront Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,932	Closed	-$394K	–	591
2025 Q4	$394K	Buy	+5,932	New	+$384K	0.1%	322
2025 Q2	–	Sell	-6,712	Closed	-$458K	–	665
2025 Q1	$458K	Buy	6,712 +2,953	+79%	+$241K	0.13%	278
2024 Q4	$292K	Sell	3,759 -10,437	-74%	-$773K	0.1%	366
2024 Q3	$952K	Buy	+14,196	New	+$1.17M	0.37%	53
2024 Q1	–	Sell	-2,510	Closed	-$311K	–	423
2023 Q4	$311K	Buy	+2,510	New	+$256K	0.24%	166
2022 Q1	–	Sell	-2,012	Closed	-$270K	–	311
2021 Q4	$270K	Buy	+2,012	New	+$289K	0.26%	170

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bridgefront Capital's DXCM Position: Q1 2026 in Review

Bridgefront Capital sold out of DexCom (DXCM) in Q1 2026, closing a stake of 5,932 shares — an estimated $394K sold.

Bridgefront Capital first reported a position in DXCM in Q4 2021 and held it in 6 quarters. The position peaked at $952K in Q3 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Bridgefront Capital reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Bridgefront Capital sold 5,932 DexCom shares in Q1 2026, an estimated $394K.
Bridgefront Capital first reported a position in DexCom in Q4 2021 and held it in 6 quarters.
Bridgefront Capital's DexCom position peaked at $952K in Q3 2024.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.